Cite
Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma
MLA
Lisa H. Butterfield, et al. “Multiple Antigen-Engineered DC Vaccines with or without IFNα to Promote Antitumor Immunity in Melanoma.” Journal for ImmunoTherapy of Cancer, vol. 7, no. 1, Apr. 2019, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s40425-019-0552-x.
APA
Lisa H. Butterfield, Lazar Vujanovic, Patricia M. Santos, Deena M. Maurer, Andrea Gambotto, Joel Lohr, Chunlei Li, Jacob Waldman, Uma Chandran, Yan Lin, Huang Lin, Hussein A. Tawbi, Ahmad A. Tarhini, & John M. Kirkwood. (2019). Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma. Journal for ImmunoTherapy of Cancer, 7(1), 1–15. https://doi.org/10.1186/s40425-019-0552-x
Chicago
Lisa H. Butterfield, Lazar Vujanovic, Patricia M. Santos, Deena M. Maurer, Andrea Gambotto, Joel Lohr, Chunlei Li, et al. 2019. “Multiple Antigen-Engineered DC Vaccines with or without IFNα to Promote Antitumor Immunity in Melanoma.” Journal for ImmunoTherapy of Cancer 7 (1): 1–15. doi:10.1186/s40425-019-0552-x.